Acquisition

SoftBank's move to delist French robotics firm BALYO offers a premium to shareholders but signals a larger consolidation in the automated logistics space.

Beyond a massive cookie giveaway, Dirty Dough is engineering loyalty and fueling franchise growth. Here's the strategy behind their 'Free for Life' campaign.

A last-minute regulatory filing by Balyasny Asset Management pulls back the curtain on the multi-billion-dollar battle for Spectris, a key health tech enabler.

The firm’s steady dividend is not just a routine payout. It's a signal of financial strength, a strategic balance of growth, and a key tax advantage.

A regulatory filing shows hedge fund Balyasny's active trading in Avadel Pharma, exposing a merger arbitrage strategy amid a fierce bidding war.

A routine financial disclosure from an asset manager unveils Qualcomm's $2.4B bet on Alphawave, signaling a major push into the AI infrastructure that powers health tech.

A regulatory filing reveals Balyasny Asset Management's strategic trading in Just Group as the stock hits a 52-week high during a takeover.

Nick Ace, a top designer for NASA and Google, joins MoonPay's creative agency. Here's why this strategic hire is a game-changer for Web3 adoption.

A recent tree care acquisition reveals a deeper strategy: private equity is building scale not just for profit, but to deploy AI and revolutionize work.

A Salesforce-backed consultancy is betting on deep practitioner experience to shake up the slow-moving world of government modernization. Here's why.

Facing a 70% stock decline, High Roller Technologies is shaking up its marketing. Can two industry veterans redefine the user experience and win the iGaming wars?

A 70-year leader in fire-retardant wood acquires an aluminum cladding giant, signaling a major shift toward integrated, 'inside-out' building protection.

The Drone-as-a-Service market is set for explosive growth, creating massive opportunities and complex digital risks from mining to modern warfare.

SkinSpirit's new Princeton clinic isn't just an expansion; it's a strategic move in the booming medical aesthetics market. Here's why it matters.

With new EHR integrations and a direct-to-provider model, Speke AI is making its ambient intelligence tools more accessible than ever. Is this the tipping point?

The medtech giant projects robust growth with an ambitious pipeline, but a high-stakes regulatory showdown over a key acquisition could redefine its future.